Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The brand name for exenatide became Byetta, which was approved by the FDA in 2005 for the treatment of type 2 diabetes
Lets walk through it
Background Background GLP-1 inhibitor drugs are now used by over 12% of Americans, and the numbers are expected to climb
These conditions can rapidly worsen and may be life-threatening without prompt treatment
Its marketed as Ozempic for diabetes and Wegovy for weight loss
Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on -cell function in Asian and Caucasian type 2 diabetes mellitus patients: a meta-analysis
US$ 23.17
US$ 21.90
US$ 29.09
US$ 26.01
US$ 23.25
US$ 20.12
US$ 28.73
US$ 20.30
US$ 23.36
